Role of antireflux mucosal ablation in "reflux-predominant" refractory gastroesophageal reflux disease: a randomized sham-controlled trial
GastroenterologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Endoscopy
- Publicado em
- 6 nov 2025
- Citações
- 8
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Role of antireflux mucosal ablation in "reflux-predominant" refractory gastroesophageal reflux disease: a randomized sham-controlled trial
Digvijay Chavan, Krithi Krishna Koduri, Aniruddha Pratap Singh, Rajesh Goud Maragoni, Nitin Jagtap, Rakesh Kalapala, D Nageshwar Reddy
Descritores MeSH
- Gastroesophageal Reflux
- Endoscopic Mucosal Resection
- Female
- Heartburn
- Humans
- Male
- Middle Aged
- Quality of Life
- Treatment Outcome
- Esophageal pH Monitoring
Veja também
Estudos relacionados
- Efficacy and safety of antireflux mucosectomy versus radiofrequency ablation of the lower esophageal sphincter for the treatment of GERD: a systematic review and meta-analysis
- A Meta-analysis of PPIs Plus Alginate Versus PPIs Alone for the Treatment of GERD
- Uncovering the Mechanisms of Failure of Proton Pump Inhibitors in GERD: The Role of Esophageal Acid Sensitivity
- Randomised clinical trial: Efficacy and safety of on-demand vonoprazan versus placebo for non-erosive reflux disease